Event 
Partner 
Milestone 
2021-01-15
Taiwan Healthcare Data Preservation Platform Initiative
The Taiwan government initiative "Taiwan Precision Medicine Collaboration Initiatives" with ACT Genomics, Novartis Taiwan, and Pfizer Taiwan.
Place:
Taiwan
2021-01-06
2021/1/17 Upcoming Advance Precision Cancer Medicine Forum
Advance Precision Cancer Medicine Forum (APCM)
Place:
Taipei
2020-11-19
ASUS, KMUH and ACT Genomics Collaborate to Develop AI-based Precision Cancer Medicine Solutions for Cancer Patients
The collaboration among ASUS, KMUH and ACT Genomics aim to utilize NGS tumor profiling service, cancer genomic database and Intelligent Cloud Service Center (AICS) EMR search to intelligently assist physicians to develop treatment plans.
Place:
Taiwan
2020-11-17
ACT Genomics Have Been Awarded With ISO/IEC 27001 Certification
The ISO/IEC 27001 certification helps to increase clients’ confidence in our information security management, enabling us to promote innovative cancer genomic profiling services with our international partners.
Place:
Taiwan
2020-11-17
ACT Genomics Is The Member Of The Global Alliance For Genomics And Health (GA4GH)
ACT Genomics is now an organizational member of the Global Alliance for Genomics and Health (GA4GH) and we will continue to promote cancer precision medicine.
Place:
Taiwan
2020-11-10
Teddy Lab, A Central Lab Partner Of ACT Genomics, And AstraZeneca China Signed Strategic MOU To Develop Cancer Precision Medicine Solution In China
Teddy Lab and AstraZeneca China signed strategic MOU for the CDx development of HRD, the standardization of sequencing and commercialization to provide cancer patients precision diagnosis and treatment as one-stop service.
Place:
China
2020-10-22
11/07 & 08 Upcoming Annual 7th Hong Kong International Oncology Symposium
ACT Genomics co-organizes the 7th Hong Kong International Oncology Symposium (HKIOS) to invite experts to share their first-hand experience with this groundbreaking advances in cancer management to speed up the progress of clinical practice.
Place:
Hong Kong
2020-09-29
ACT Genomics and Nan Shan Life Insurance Cooperates To Promote High-Quality Cancer Precision Medicine Services
To provide better care for cancer patients in precision medicine, strategic cooperations among biotech and insurance company are on the rise. We are happy to announce that ACT Genomics cooperates with Nan Shan Life Insurance for precision medicine project
Place:
Taipei
2020-09-28
ACTRisk™ Genetic Test For Hereditary Cancers - Start You & Your Family's Hereditary Medical Plan Better And Earlier
Approximately 5–10% of cancers are caused by inherited genetic mutations, and through high-quality hereditary genetic test ACTRisk™ , you and your family can start your hereditary medical plan better and earlier.
Place:
Taipei
2020-09-07
ACT Genomics Completed the First Closing of latest Round of Equity Financing
ACT Genomics is pleased to announce the completion of the first closing of the latest round of equity financing from a group of strategic investors including Aflac Ventures LLC and Kyoto University Innovation Capital.
Place:
Asia
